Array comparative genomic hybridization analysis revealed four genomic prognostic biomarkers for primary gastric cancers

Cancer Genetics and Cytogenetics

Volumn 201, Issue 1, 2010, Pages 6-14

  Tomioka, Nobumoto ^a   Morita, Keiko ^b   Kobayashi, Nozomi ^a   Tada, Mitsuhiro ^c   Itoh, Tomoo ^d   Saitoh, Soichiro ^b   Kondo, Masao ^a   Takahashi, Norihiko ^a   Kataoka, Akihiko ^a   Nakanishi, Kazuaki ^a   Takahashi, Masato ^a   Kamiyama, Toshiya ^a   Ozaki, Michitaka ^a   Hirano, Takashi ^b   Todo, Satoru ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE GLUCOSYLTRANSFERASE; CISPLATIN; FLUOROURACIL; HOMEODOMAIN PROTEIN; ONCOPROTEIN; PROTEIN CASC3; PROTEIN HOXB3; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADVANCED CANCER; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE DELETION; GENE IDENTIFICATION; GENE LOCUS; GENETIC MARKER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MOLECULAR CLONING; POSTOPERATIVE PERIOD; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER;

BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DNA PRIMERS; GENOME, HUMAN; HUMANS; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

BACTERIA (MICROORGANISMS);

EID: 77954656159     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.04.017     Document Type: Article

References (53)

1. Japanese Gastric Cancer Association Japanese classification of gastric carcinoma: 2nd English edition. Gastric Cancer 1998, 1:10-24.
2. Japanese Gastric Cancer Association Therapeutic guidelines for gastric carcinoma 2004, Kanehara, Tokyo, 1-39. 2nd English ed.
3. Nørsett K.G., Laegreid A., Midelfart H., Yadetie F., Erlandsen S.E., Falkmer S., et al. Gene expression based classification of gastric carcinoma. Cancer Lett 2004, 210:227-237.
4. Jinawath N., Furukawa Y., Hasegawa S., Li M., Tsunoda T., Satoh S., et al. Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray. Oncogene 2004, 23:6830-6844.
5. Motoori M., Takemasa I., Yano M., Saito S., Miyata H., Takiguchi S., et al. Prediction of recurrence in advanced gastric cancer patients after curative resection by gene expression profiling. Int J Cancer 2005, 114:963-968.
6. Teramoto K., Tada M., Tamoto E., Abe M., Kawakami A., Komuro K., et al. Prediction of lymphatic invasion/lymph node metastasis, recurrence, and survival in patients with gastric cancer by cDNA array-based expression profiling. J Surg Res 2005, 124:225-236.
7. Tay S.T., Leong S.H., Yu K., Aggarwal A., Tan S.Y., Lee C.H., et al. A combined comparative genomic hybridization and expression microarray analysis of gastric cancer reveals novel molecular subtypes. Cancer Res 2003, 63:3309-3316.
8. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 2004, 4:688-694.
9. Murata-Kamiya N., Kurashima Y., Teishikata Y., Yamahashi Y., Saito Y., Higashi H., et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the β-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 2007, 26:4617-4626.
10. Saadat I., Higashi H., Obuse C., Umeda M., Murata-Kamiya N., Saito Y., et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007, 447:330-333.
11. Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988, 319:525-532.
12. Albertson D.G., Collins C., McCormick F., Gray J.W. Chromosome aberrations in solid tumors. Nat Genet 2003, 34:369-376.
13. Tomioka N., Kobayashi H., Kageyama H., Ohira M., Nakamura Y., Sasaki F., et al. Chromosomes that show partial loss or gain in near-diploid tumors coincide with chromosomes that show whole loss or gain in near-triploid tumors: evidence suggesting the involvement of the same genes in the tumorigenesis of high- and low-risk neuroblastomas. Genes Chromosomes Cancer 2003, 36:139-150.
14. Houghton J., Stoicov C., Nomura S., Rogers A.B., Carlson J., Li H., et al. Gastric cancer originating from bone marrow-derived cells. Science 2004, 306:1568-1571.
15. Correa P., Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007, 133:659-672.
16. Weiss M.M., Kuipers E.J., Postma C., Snijders A.M., Siccama I., Pinkel D., et al. Genomic profiling of gastric cancer predicts lymph node status and survival. Oncogene 2003, 22:1872-1879.
17. Tomioka N., Oba S., Ohira M., Misra A., Fridlyand J., Ishii S., et al. Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature. Oncogene 2008, 27:441-449.
18. Pinkel D., Segraves R., Sudar D., Clark S., Poole I., Kowbel D., et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998, 20:207-211.
19. Klein C.A., Schmidt-Kittler O., Schardt J.A., Pantel K., Speicher M.R., Riethmuller G. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc Natl Acad Sci U S A 1999, 96:4494-4499.
20. Snijders A.M., Nowak N., Segraves R., Blackwood S., Brown N., Conroy J., et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 2001, 29:263-264.
21. Kang J.U., Kang J.J., Kwon K.C., Park J.W., Jeong T.E., Noh S.M., et al. Genetic alterations in primary gastric carcinomas correlated with clinicopathological variables by array comparative genomic hybridization. J Korean Med Sci 2006, 21:656-665.
22. Do J.H., Kim I.S., Park T.K., Choi D.K. Genome-wide examination of chromosomal aberrations in neuroblastoma SH-SY5Y cells by array-based comparative genomic hybridization. Mol Cells 2007, 24:105-112.
23. Watanabe Y., Toyota M., Kondo Y., Suzuki H., Imai T., Ohe-Toyota M., et al. PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer. Clin Cancer Res 2007, 13:4786-4794.
24. Ray M.E., Wistow G., Su Y.A., Meltzer P.S., Trent J.M. AIM1, a novel non-lens member of the βγ-crystallin superfamily, is associated with the control of tumorigenicity in human malignant melanoma. Proc Natl Acad Sci U S A 1997, 94:3229-3234.
25. Jackson A., Panayiotidis P., Foroni L. The human homologue of the Drosophila tailless gene (TLX): characterization and mapping to a region of common deletion in human lymphoid leukemia on chromosome 6q21. Genomics 1998, 50:34-43.
26. Yamashita T., Wada R., Sasaki T., Deng C., Bierfreund U., Sandhoff K., et al. A vital role for glycosphingolipid synthesis during development and differentiation. Proc Natl Acad Sci U S A 1999, 96:9142-9147.
27. Lang T., Hansson G.C., Samuelsson T. Gel-forming mucins appeared early in metazoan evolution. Proc Natl Acad Sci U S A 2007, 104:16209-16214.
28. Zachariae W., Shin T.H., Galova M., Obermaier B., Nasmyth K. Identification of subunits of the anaphase-promoting complex of Saccharomyces cerevisiae. Science 1996, 274:1201-1204.
29. Bolognese F., Forni C., Caretti G., Frontini M., Minuzzo M., Mantovani R. The Pole3 bidirectional unit is regulated by MYC and E2Fs. Gene 2006, 366:109-116.
30. Schmucker D., Zipursky S.L. Signaling downstream of Eph receptors and ephrin ligands. Cell 2001, 105:701-704.
31. Degot S., Régnier C.H., Wendling C., Chenard M.P., Rio M.C., Tomasetto C. Metastatic lymph node 51, a novel nucleo-cytoplasmic protein overexpressed in breast cancer. Oncogene 2002, 21:4422-4434.
32. Nakamura Y., Tanaka F., Nagahara H., Ieta K., Haraguchi N., Mimori K., et al. Opa interacting protein 5 (OIP5) is a novel cancer-testis specific gene in gastric cancer. Ann Surg Oncol 2007, 14:885-892.
33. Barre F.X., Søballe B., Michel B., Aroyo M., Robertson M., Sherratt D. Circles: the replication-recombination-chromosome segregation connection. Proc Natl Acad Sci U S A 2001, 98:8189-8195.
34. Wang Y.F., Daniel E.E. Gap junctions in gastrointestinal muscle contain multiple connexins. Am J Physiol Gastrointest Liver Physiol 2001, 281:G533-G543.
35. Varis A., Wolf M., Monni O., Vakkari M.L., Kokkola A., Moskaluk C., et al. Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res 2002, 62:2625-2629.
36. Guo Y.S., Beauchamp R.D., Jin G.F., Townsend C.M., Thompson J.C. Insulinlike growth factor-binding protein modulates the growth response to insulinlike growth factor 1 by human gastric cancer cells. Gastroenterology 1993, 104:1595-1604.
37. Srebrow A., Friedmann Y., Ravanpay A., Daniel C.W., Bissell M.J. Expression of Hoxa-1 and Hoxb-7 is regulated by extracellular matrix-dependent signals in mammary epithelial cells. J Cell Biochem 1998, 69:377-391. [Erratum in: J Cell Biochem 1998;71:310-312].
38. Carè A., Felicetti F., Meccia E., Bottero L., Parenza M., Stoppacciaro A., et al. HOXB7: a key factor for tumor-associated angiogenic switch. Cancer Res 2001, 61:6532-6539.
39. López R., Garrido E., Piña P., Hidalgo A., Lazos M., Ochoa R., et al. HOXB homeobox gene expression in cervical carcinoma. Int J Gynecol Cancer 2006, 16:329-335.
40. Rubin E., Wu X., Zhu T., Cheung J.C.Y., Chen H., Lorincz A., et al. A role for the HOXB7 homeodomain protein in DNA repair. Cancer Res 2007, 67:1527-1535.
41. Wang Q., Moyret-Lalle C., Couzon F., Surbiguet-Clippe C., Saurin J.C., Lorca T., et al. Alterations of anaphase-promoting complex genes in human colon cancer cells. Oncogene 2003, 22:1486-1490.
42. Yoo N.J., Soung Y.H., Lee S.H., Jeong E.G., Lee S.H. Mutational analysis of proapoptotic integrin beta 3 cytoplasmic domain in common human cancers. Tumori 2007, 93:281-283.
43. Bouwmeester T., Bauch A., Ruffner H., Angrand P.O., Bergamini G., Croughton K., et al. A physical and functional map of the human TNF-α/NF-κB signal transduction pathway. Nat Cell Biol 2004, [Erratum in: Nat Cell Biol 2004;6:465], 697-105.
44. Monteleone G., Del Vecchio Blanco G., Palmieri G., Vavassori P., Monteleone I., Colantoni A., et al. Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection. Gastroenterology 2004, 126:674-682.
45. Ngo E.O., LePage G.R., Thanassi J.W., Meisler N., Nutter L.M. Absence of pyridoxine-5'-phosphate oxidase (PNPO) activity in neoplastic cells: isolation, characterization, and expression of PNPO cDNA. Biochemistry 1998, 37:7741-7748.
46. Kourmouli N., Dialynas G., Petraki C., Pyrpasopoulou A., Singh P.B., Georgatos S.D., et al. Binding of heterochromatin protein 1 to the nuclear envelope is regulated by a soluble form of tubulin. J Biol Chem 2001, 276:13007-13014.
47. Kosco K.A., Cerignoli F., Williams S., Abraham R.T., Mustelin T. SKAP55 modulates T cell antigen receptor-induced activation of the Ras-Erk-AP1 pathway by binding RasGRP1. Mol Immunol 2008, 45:510-522.
48. Gu X., Zhao F., Zheng M., Fei X., Chen X., Huang S., et al. Cloning and characterization of a gene encoding the human putative ubiquitin conjugating enzyme E2Z (UBE2Z). Mol Biol Rep 2007, 34:183-188.
49. Dohi T., Yuyama Y., Natori Y., Smith P.L., Lowe J.B., Oshima M. Detection of N-acetylgalactosaminyltransferase mRNA which determines expression of Sda blood group carbohydrate structure in human gastrointestinal mucosa and cancer. Int J Cancer 1996, 67:626-631.
50. Li Q.L., Ito K., Sakakura C., Fukamachi H., Inoue K., Chi X.Z., et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002, 109:113-124.
51. Guo W.H., Weng L.Q., Ito K., Chen L.F., Nakanishi H., Tatematsu M., et al. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. Oncogene 2002, 21:8351-8355.
52. Brenner O., Levanon D., Negreanu V., Golubkov O., Fainaru O., Woolf E., et al. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc Natl Acad Sci U S A 2004, 101:16016-16021.
53. Roukos D.H. Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies. Expert Rev Mol Diagn 2008, 8:29-39.